As of 2025-03-26, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.94) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.60 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -346.1%.
The range of the Relative Valuation is (3.15) - (4.72) CAD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 7.2x - 10.8x | 9.0x |
| Fair Price | (3.15) - (4.72) | (3.94) |
| Upside | -296.8% - -395.3% | -346.1% |
| Date | P/E |